Nexelis.com isn't a startup—it's the digital front door for a $47.6M laboratory powerhouse embedded within the IQVIA empire. While most biotech labs fight for scraps, this operation leverages a global network to deliver clinical trial outcomes that pharma giants depend on. The website may be sparse, but the business behind it is anything but.

"When your website traffic is zero but your revenue is $47M, you're not selling to consumers—you're solving for enterprise clients who already know your number."

The leadership team tells the story: Timothy McGrath (COO), Tonya Aggoune (VP Data/IT), and Saadya Fatmi (VP Operations) form a triad focused on execution, not marketing. This is a company that wins by doing the work, not by being found online. The single tracked keyword—'bio tech industries indidana'—reveals their audience: industry insiders searching for specialized regional capabilities.

• Enterprise-first model: Revenue comes from contracts, not conversions
• IQVIA ecosystem advantage: Leverages parent company's clinical trial infrastructure
• Zero-traffic strategy: Not a bug, but a feature of their B2B lab services model
• Specialized keyword capture: Dominating niche industry terms over broad search